May 14, 2021
Article
The single 1000 mg dose treats iron deficiency anemia in adult patients.
May 12, 2021
Bayer has submitted a New Drug Application for the mineralocorticoid receptor antagonist.
May 10, 2021
More than 40% of the treatment arm of the placebo-controlled trial achieved a complete renal response.
April 30, 2021
The SGLT2 inhibitor is the first of its class to receive indication for treating kidney outcomes regardless of a patient's diabetes status.
Agency requests additional analyses on the novel mechanism of action on the serum phosphorus treatment for chronic kidney disease patients on dialysis.
April 14, 2021
A new study on dapagliflozin use finds consistent risk reduction in treatment of patients with higher rates of kidney dysfunction.
April 12, 2021
Medtronic claims the GI Genius module will help clinicals identify lesions in real time during a colonoscopy.
April 05, 2021
Many believed radiocontrast exposure could be linked to long-term kidney impairment.
March 23, 2021
As a multi-systemic disorder, Fabry disease can impact the functions of various organs. As a genetic disorder, Fabry can impact the offsprings, parents, and relatives of the patient. Therefore, its effects are far-reaching.
March 16, 2021
Podcast
Eric Wallace, MD, discusses Anderson-Fabry disease and the difficulties associated with screening, testing, and treatment.
